Foundation of Research and Science Development
www.fundacjabirn.plFoundation on Research and Development is a scientific unit. We are working on the project of 3D bionic pancreas, which will revolutionize treatment of diabetes type I in Poland and the rest of the world. Thanks to a living organ printed in 3D bioprinter, it will be possible to transplant to a human being a living organ that is tailormade and to treat diabetes type I, a disease currently classified as incurable. It is estimated that there are ca. 3 million persons in Poland affected by diabetes and 200k of them are suffering from diabetes type I. Unfortunately, the number of persons that do not react positively to applied diabetes treatment therapies and develop dangerous complications is constantly increasing. Nowadays, the only method to cure the disease completely is to transplant pancreas or pancreatic islets. However, these methods are difficult and full of flaws such as permanent lack of organs for transplantations, chronic immunosuppression or the risk of surgical complications following pancreas transplantation. The solution to this problem is a tailormade pancreas – a fully functional organ created from stem cells of the patient and printed in 3D bioprinting technology. This is being worked on by the Polish scientists from the Foundation on Research and Science Development. Foundation’s team comprises of talented and enthusiastic scientists with innovative, engaged and creative attitude such as biotechnologists, chemists, engineers, laboratory technologists as well as doctors and medical consultants under the supervision of the President of Scientific Board M.D. dr hab. Michał Wszoła, a transplantation surgeon, a visionary scientist with extensive experience in battle against complications following diabetes, the author of bionic pancreas. We are proud to have been nominated to the title of Polish Science Ambassador in 2019 and 2020.
Read moreReach decision makers at Foundation of Research and Science Development
Free credit every month!
Foundation on Research and Development is a scientific unit. We are working on the project of 3D bionic pancreas, which will revolutionize treatment of diabetes type I in Poland and the rest of the world. Thanks to a living organ printed in 3D bioprinter, it will be possible to transplant to a human being a living organ that is tailormade and to treat diabetes type I, a disease currently classified as incurable. It is estimated that there are ca. 3 million persons in Poland affected by diabetes and 200k of them are suffering from diabetes type I. Unfortunately, the number of persons that do not react positively to applied diabetes treatment therapies and develop dangerous complications is constantly increasing. Nowadays, the only method to cure the disease completely is to transplant pancreas or pancreatic islets. However, these methods are difficult and full of flaws such as permanent lack of organs for transplantations, chronic immunosuppression or the risk of surgical complications following pancreas transplantation. The solution to this problem is a tailormade pancreas – a fully functional organ created from stem cells of the patient and printed in 3D bioprinting technology. This is being worked on by the Polish scientists from the Foundation on Research and Science Development. Foundation’s team comprises of talented and enthusiastic scientists with innovative, engaged and creative attitude such as biotechnologists, chemists, engineers, laboratory technologists as well as doctors and medical consultants under the supervision of the President of Scientific Board M.D. dr hab. Michał Wszoła, a transplantation surgeon, a visionary scientist with extensive experience in battle against complications following diabetes, the author of bionic pancreas. We are proud to have been nominated to the title of Polish Science Ambassador in 2019 and 2020.
Read moreCountry
City (Headquarters)
Warsaw
Industry
Employees
11-50
Founded
2009
Social
Employees statistics
View all employeesPotential Decision Makers
Principal Investigator
Email ****** @****.comPhone (***) ****-****
Technologies
(24)